NIASPAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Niaspan, and when can generic versions of Niaspan launch?
Niaspan is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in NIASPAN is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Niaspan
A generic version of NIASPAN was approved as niacin by BARR on April 14th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NIASPAN?
- What are the global sales for NIASPAN?
- What is Average Wholesale Price for NIASPAN?
Summary for NIASPAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Clinical Trials: | 45 |
Patent Applications: | 4,134 |
Drug Prices: | Drug price information for NIASPAN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NIASPAN |
What excipients (inactive ingredients) are in NIASPAN? | NIASPAN excipients list |
DailyMed Link: | NIASPAN at DailyMed |
Recent Clinical Trials for NIASPAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cortria Corporation | Phase 1 |
PPD | Phase 1 |
Pharmena North America | Phase 1 |
US Patents and Regulatory Information for NIASPAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-004 | Jul 28, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-003 | Jul 28, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-001 | Jul 28, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NIASPAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-002 | Jul 28, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-001 | Jul 28, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | NIASPAN | niacin | TABLET, EXTENDED RELEASE;ORAL | 020381-001 | Jul 28, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NIASPAN
See the table below for patents covering NIASPAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 9815457 | ⤷ Sign Up | |
Norway | 994275 | ⤷ Sign Up | |
European Patent Office | 0999844 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |